TY  - GEN
AU  - Mey, B. P.
CN  - K1401.A15
ID  - 26282
KW  - Intellectual property (International law)
KW  - Copyright, International.
KW  - Patents (International law)
KW  - Dispute resolution (Law)
KW  - Intellectual property
KW  - Case studies
KW  - TRIPS
KW  - Drugs
KW  - Propriété intellectuelle (Droit international)
L1  - http://dx.doi.org/10.1111/j.1747-1796.2009.00392.x
L1  - DOI: 10.1111/j.1747-1796.2008.00344.x
L2  - http://dx.doi.org/10.1111/j.1747-1796.2009.00392.x
L2  - DOI: 10.1111/j.1747-1796.2008.00344.x
L4  - http://dx.doi.org/10.1111/j.1747-1796.2009.00392.x
L4  - DOI: 10.1111/j.1747-1796.2008.00344.x
LA  - eng
LK  - http://dx.doi.org/10.1111/j.1747-1796.2009.00392.x
LK  - DOI: 10.1111/j.1747-1796.2008.00344.x
T1  - Unfettered Consumer Access to Affordable Therapies in the Post-TRIPS Era :A Dead-End Journey for Patients? Kenya and India Case Studies.
TI  - Unfettered Consumer Access to Affordable Therapies in the Post-TRIPS Era :A Dead-End Journey for Patients? Kenya and India Case Studies.
UR  - http://dx.doi.org/10.1111/j.1747-1796.2009.00392.x
UR  - DOI: 10.1111/j.1747-1796.2008.00344.x
VL  - CH 51 Jan 2010 Vol. 13 No. 3 pages 403-473
ER  -